- ICH GCP
- US Clinical Trials Registry
- Researchers
- Argentina
- Carcinoma, Non-Small-Cell Lung
Medical specialists from Argentina tagged as investigators in clinical trials studying Carcinoma, Non-Small-Cell Lung
Total 24 results
-
Aldo Agustín PerfettiSeen in:
- Buenos Aires, Ciudad Autonoma Buenos Aires, GSK Investigational Site
Trials:- NCT05565378 (Principal Investigator)
Conditions: -
Alvaro RomeraSeen in:
- Santa Fe, Rosario, GSK Investigational Site
Trials:- NCT04475939 (Principal Investigator)
Conditions: -
Christian Sebastian FuentesSeen in:
- Buenos Air, Buenos Aires, Fundación Respirar
- Buenos Aires, Ciudad Autonoma de Buenos Aires, GSK Investigational Site
- Buenos Aires, Ciudad Autónoma de Buenos Aires, GSK Investigational Site
- Buenos Aires, Fundación Respirar
Trials:- NCT05169567 (Principal Investigator)
- NCT05288166 (Principal Investigator)
- NCT05514054 (Principal Investigator)
- NCT05565378 (Principal Investigator)
- NCT06062420 (Principal Investigator)
- NCT06256588 (Principal Investigator)
Conditions:- Neoplasm Metastasis;
- Breast Neoplasm;
- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6;
- Breast Neoplasms;
- Lung Cancer, Non-Small Cell;
- Neoplasms, Head and Neck
-
Cristian Andres BuonoSeen in:
- Mar del Plata, GSK Investigational Site
Trials:- NCT04475939 (Principal Investigator)
Conditions: -
Cristina Nasurdi, MDSeen in:
- Santa Fe, Rosario, Sanatorio de la Mujer
Trials:- NCT05668650 (Principal Investigator)
Conditions: -
Diego Abellan Von FarkasSeen in:
- Santa Fe, Rosario, GSK Investigational Site
Trials:- NCT04655976 (Principal Investigator)
Conditions: -
Diego KaenSeen in:
- La Rioja, Centro Oncologico Riojano Integral
- La Rioja, GSK Investigational Site
Trials:- NCT04655976 (Principal Investigator)
- NCT03596866 (Principal Investigator)
Conditions: -
Enrique Fermin AmanSeen in:
- Buenos Aires, Ciudad Autonoma de Buenos Aires, GSK Investigational Site
Trials:- NCT05565378 (Principal Investigator)
Conditions: -
Felipe PalazzoSeen in:
- Tucuman, San Miguel De Tucuman, Centro para la Atención Integral del paciente Oncológico
Trials:- NCT03596866 (Principal Investigator)
Conditions: -
Gaston Lucas MartinengoSeen in:
- Santa Fe, Rosario, GSK Investigational Site
Trials:- NCT04475939 (Principal Investigator)
Conditions: -
Geronimo RosselliSeen in:
- Ciudad Autonoma de Buenos Aires, GSK Investigational Site
Trials:- NCT05565378 (Principal Investigator)
Conditions: -
Gladys PazSeen in:
- Buenos Aires, Berazategui, Centro de Oncología e Investigación de Buenos Aires
Trials:- NCT04194944 (Principal Investigator)
Conditions: -
Guillermo Streich, MDSeen in:
- Buenos Aires, Centro Medico Austral
Trials:- NCT05668650 (Principal Investigator)
Conditions: -
Gustavo Alberto LopezSeen in:
- Buenos Aires, Florida, GSK Investigational Site
Trials:- NCT04475939 (Principal Investigator)
- NCT02715284 (Principal Investigator)
- NCT05565378 (Principal Investigator)
- NCT06062420 (Principal Investigator)
Conditions: -
Jose Nicolas MinattaSeen in:
- Buenos Aires, GSK Investigational Site
Trials:- NCT05565378 (Principal Investigator)
Conditions: -
Jose Roberto LlugdarSeen in:
- San Juan, Clinica El Castano
Trials:- NCT04194944 (Principal Investigator)
Conditions: -
Juan Manuel PuigSeen in:
- San Juan, Centro Polivalente de Asistencia e Investigacion Clinica - CER San Juan
- San Juan, Cer San Juan
- San Juan, GSK Investigational Site
Trials:- NCT05169567 (Principal Investigator)
- NCT05288166 (Principal Investigator)
- NCT05514054 (Principal Investigator)
- NCT05565378 (Principal Investigator)
- NCT06062420 (Principal Investigator)
- NCT06256588 (Principal Investigator)
Conditions:- Neoplasm Metastasis;
- Breast Neoplasm;
- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6;
- Breast Neoplasms;
- Lung Cancer, Non-Small Cell;
- Neoplasms, Head and Neck
-
Lisandro VimoSeen in:
- Buenos Aires, La Plata, GSK Investigational Site
Trials:- NCT04475939 (Principal Investigator)
Conditions: -
Lucas PrattaSeen in:
- Santa Fe, GSK Investigational Site
Trials:- NCT05565378 (Principal Investigator)
- NCT05855200 (Principal Investigator)
- NCT06062420 (Principal Investigator)
-
Luciano PiazzoniSeen in:
- Neuquén, Fundacion Medica de Rio Negro y Neuquen
- Río Negro, Cipoletti, GSK Investigational Site
- Río Negro, Cipoletti, Rio Negro, GSK Investigational Site
Trials:- NCT04475939 (Principal Investigator)
- NCT05565378 (Principal Investigator)
- NCT05857397 (Principal Investigator)
Conditions: -
Nicolas CastagnerisSeen in:
- Cordoba, GSK Investigational Site
Trials:- NCT04475939 (Principal Investigator)
Conditions: -
Omar Esteban CarranzaSeen in:
- Buenos Aires, Mar del Plata, GSK Investigational Site
Trials:- NCT05565378 (Principal Investigator)
Conditions: -
Ruben Dario KowalyszynSeen in:
- Río Negro, Viedma, Clinica Viedma
- Río Negro, Viedma, Clinica Viedma S. A
- Río Negro, Viedma, GSK Investigational Site
Trials:- NCT05288166 (Principal Investigator)
- NCT04194944 (Principal Investigator)
- NCT04655976 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6;
- Non-Small Cell Lung Cancer;
- Lung Cancer, Non-Small Cell
-
Susana KahlSeen in:
- Buenos Aires, Pergamino, GSK Investigational Site
Trials:- NCT04655976 (Principal Investigator)
Conditions:
Clinical Trials on Carcinoma, Non-Small-Cell Lung
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Bristol-Myers SquibbCompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage I Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma | Non-Squamous Non-Small...United States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingLung Non-Squamous Non-Small Cell Carcinoma | Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7United States, Puerto Rico
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Recurrent Lung Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IA...United States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Society of Thoracic RadiologyActive, not recruitingStage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingStage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage I Lung Non-Small Cell Cancer AJCC v7 | Stage...United States
-
National Cancer Institute (NCI)Active, not recruitingStage IIIA Lung Non-Small Cell Cancer AJCC v7 | Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC...United States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States